id | C00003617 |
---|---|
Name | Digitoxin |
CAS RN | 71-63-6 |
Standard InChI | InChI=1S/C41H64O13/c1-20-36(46)29(42)16-34(49-20)53-38-22(3)51-35(18-31(38)44)54-37-21(2)50-33(17-30(37)43)52-25-8-11-39(4)24(15-25)6-7-28-27(39)9-12-40(5)26(10-13-41(28,40)47)23-14-32(45)48-19-23/h14,20-22,24-31,33-38,42-44,46-47H,6-13,15-19H2,1-5H3/t20?,21?,22?,24-,25+,26-,27+,28-,29+,30-,31+,33+,34-,35-,36?,37-,38?,39+,40-,41+/m1/s1 |
Standard InChI (Main Layer) | InChI=1S/C41H64O13/c1-20-36(46)29(42)16-34(49-20)53-38-22(3)51-35(18-31(38)44)54-37-21(2)50-33(17-30(37)43)52-25-8-11-39(4)24(15-25)6-7-28-27(39)9-12-40(5)26(10-13-41(28,40)47)23-14-32(45)48-19-23/h14,20-22,24-31,33-38,42-44,46-47H,6-13,15-19H2,1-5H3 |
Phytochemical cluster | No. 56 |
---|---|
KCF-S cluster | No. 272 |
By standard InChI | |
---|---|
By standard InChI Main Layer | CHEMBL267817 CHEMBL254219 CHEMBL1324812 CHEMBL1899295 |
By LinkDB | C06955 |
---|
By CAS RN | D004074 |
---|
class name | count |
---|---|
asterids | 1 |
family name | count |
---|---|
Plantaginaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Digitalis purpurea | 4164 | Plantaginaceae | asterids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL254219 |
CHEMBL1909136
(2)
|
1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL254219 CHEMBL1324812 |
CHEMBL1613992
(2)
|
7 / 44 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL1324812 |
CHEMBL1613842
(1)
|
4 / 2 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL254219 |
CHEMBL1909139
(2)
|
0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | CHEMBL254219 |
CHEMBL965575
(1)
|
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL254219 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL254219 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL254219 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL254219 |
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL254219 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL254219 |
CHEMBL1909176
(2)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL254219 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL254219 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL254219 |
CHEMBL1909199
(2)
|
0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL254219 |
CHEMBL1794524
(1)
CHEMBL1794552
(1)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL254219 |
CHEMBL1909197
(2)
|
2 / 2 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | CHEMBL1324812 |
CHEMBL1614331
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL267817 CHEMBL254219 |
CHEMBL1614544
(2)
|
11 / 10 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL254219 |
CHEMBL1794399
(1)
|
3 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | CHEMBL254219 |
CHEMBL1794371
(1)
CHEMBL1794471
(1)
|
0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL254219 |
CHEMBL1909123
(2)
|
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL254219 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL254219 |
CHEMBL965569
(1)
CHEMBL965573
(1)
CHEMBL1909169 (2) |
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL254219 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL254219 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL254219 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL254219 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL254219 |
CHEMBL1909090
(2)
|
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL254219 |
CHEMBL1909093
(2)
|
0 / 0 |
P02768 | Serum albumin | Secreted protein | CHEMBL254219 |
CHEMBL646313
(1)
CHEMBL702884
(1)
CHEMBL702885 (1) |
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL254219 |
CHEMBL2077338
(1)
|
1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL254219 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL254219 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL254219 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL254219 |
CHEMBL1909135
(2)
|
0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL254219 |
CHEMBL1909203
(2)
|
1 / 11 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | CHEMBL254219 |
CHEMBL1025063
(1)
CHEMBL1025064
(1)
CHEMBL1025065 (1) |
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL254219 |
CHEMBL1794376
(1)
|
2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL254219 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL254219 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL254219 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL254219 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL254219 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL254219 |
CHEMBL1909214
(2)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL254219 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL254219 |
CHEMBL1909096
(2)
|
1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL254219 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL254219 |
CHEMBL1909166
(2)
|
1 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL254219 |
CHEMBL1909133
(2)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL254219 CHEMBL1899295 |
CHEMBL1794584
(2)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL267817 CHEMBL254219 |
CHEMBL2114843
(2)
CHEMBL2114780
(2)
|
0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | CHEMBL254219 |
CHEMBL1613838
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL254219 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL254219 |
CHEMBL1909088
(2)
|
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL254219 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL254219 |
CHEMBL1909101
(2)
|
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL254219 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL254219 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL254219 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL254219 |
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL254219 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL254219 |
CHEMBL1909100
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL254219 |
CHEMBL1909167
(2)
|
1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL254219 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL254219 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL254219 |
CHEMBL1909110
(2)
|
1 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | CHEMBL254219 |
CHEMBL1614133
(1)
|
1 / 2 |
P03956 | Interstitial collagenase | M10A | CHEMBL254219 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL254219 |
CHEMBL1909119
(2)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL254219 |
CHEMBL1794382
(1)
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL254219 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL254219 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL254219 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL254219 |
CHEMBL1909109
(2)
|
2 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL254219 |
CHEMBL1794293
(1)
|
5 / 3 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL254219 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL254219 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL254219 |
CHEMBL1909114
(2)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL254219 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL254219 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL254219 |
CHEMBL1909108
(2)
|
0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | CHEMBL254219 |
CHEMBL1794437
(1)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL254219 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL254219 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL254219 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL254219 |
CHEMBL1909132
(2)
|
0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | CHEMBL254219 |
CHEMBL1614342
(1)
|
1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL254219 |
CHEMBL1738588
(1)
|
0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL254219 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL254219 |
CHEMBL1794364
(1)
CHEMBL1794542
(1)
CHEMBL1909145 (2) |
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL254219 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL254219 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL254219 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL254219 |
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL254219 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL254219 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL254219 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL254219 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL254219 |
CHEMBL1909168
(2)
|
0 / 0 |
Q02880 | DNA topoisomerase 2-beta | Isomerase | CHEMBL254219 |
CHEMBL1025066
(1)
CHEMBL1025067
(1)
CHEMBL1025069 (1) |
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL254219 |
CHEMBL1909134
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL254219 |
CHEMBL1909138
(2)
|
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL254219 |
CHEMBL1909137
(2)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL254219 |
CHEMBL1614421
(2)
|
4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL254219 |
CHEMBL1738184
(1)
CHEMBL2114890
(1)
|
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL254219 |
CHEMBL1794321
(1)
|
3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL254219 |
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL254219 |
CHEMBL1909087
(2)
|
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL254219 |
CHEMBL1909213
(2)
|
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL254219 |
CHEMBL1909089
(2)
|
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL254219 |
CHEMBL1909116
(2)
|
1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL254219 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL254219 |
CHEMBL1909128
(2)
|
0 / 0 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | CHEMBL254219 |
CHEMBL1614313
(1)
|
3 / 3 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL254219 |
CHEMBL2354311
(1)
|
1 / 0 |
Q6ZQN7 | Solute carrier organic anion transporter family member 4C1 | Unclassified protein | CHEMBL254219 |
CHEMBL2075764
(1)
|
0 / 0 |
P05023 | Sodium/potassium-transporting ATPase subunit alpha-1 | Hydrolase | CHEMBL254219 |
CHEMBL669631
(1)
|
0 / 0 |
P14415 | Sodium/potassium-transporting ATPase subunit beta-2 | potassium_sodium | CHEMBL254219 |
CHEMBL669631
(1)
|
0 / 0 |
P13637 | Sodium/potassium-transporting ATPase subunit alpha-3 | Hydrolase | CHEMBL254219 |
CHEMBL669631
(1)
|
2 / 1 |
Q13733 | Sodium/potassium-transporting ATPase subunit alpha-4 | Hydrolase | CHEMBL254219 |
CHEMBL669631
(1)
|
0 / 0 |
P54710 | Sodium/potassium-transporting ATPase subunit gamma | potassium_sodium | CHEMBL254219 |
CHEMBL669631
(1)
|
1 / 1 |
P54709 | Sodium/potassium-transporting ATPase subunit beta-3 | potassium_sodium | CHEMBL254219 |
CHEMBL669631
(1)
|
0 / 0 |
P50993 | Sodium/potassium-transporting ATPase subunit alpha-2 | Hydrolase | CHEMBL254219 |
CHEMBL669631
(1)
|
2 / 2 |
P05026 | Sodium/potassium-transporting ATPase subunit beta-1 | potassium_sodium | CHEMBL254219 |
CHEMBL669631
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D004074 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Digitoxin inhibits the reaction [ABCB1 protein results in increased transport of quinidinium] |
decreases reaction
/ increases transport |
protein |
23104431
|
D004074 | 332 |
BIRC5
API4 EPR-1 |
baculoviral IAP repeat containing 5 | Digitoxin analog results in decreased expression of BIRC5 protein |
decreases expression
|
protein |
22037315
|
D004074 | 332 |
BIRC5
API4 EPR-1 |
baculoviral IAP repeat containing 5 | Digitoxin results in decreased expression of BIRC5 protein |
decreases expression
|
protein |
22037315
|
D004074 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Digitoxin analog results in decreased expression of CASP3 protein |
decreases expression
|
protein |
22037315
|
D004074 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Digitoxin results in decreased expression of CASP3 protein |
decreases expression
|
protein |
22037315
|
D004074 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | Digitoxin analog results in increased cleavage of CASP8 protein |
increases cleavage
|
protein |
22037315
|
D004074 | 841 |
CASP8
ALPS2B CAP4 Casp-8 FLICE MACH MCH5 |
caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) | Digitoxin results in increased cleavage of CASP8 protein |
increases cleavage
|
protein |
22037315
|
D004074 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | Digitoxin analog results in increased cleavage of CASP9 protein |
increases cleavage
|
protein |
22037315
|
D004074 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | Digitoxin results in increased cleavage of CASP9 protein |
increases cleavage
|
protein |
22037315
|
D004074 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]] |
decreases reaction
/ increases expression |
protein |
19446813
|
D004074 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein] |
decreases reaction
/ increases expression |
protein |
19446813
|
D004074 | 891 |
CCNB1
CCNB |
cyclin B1 | Digitoxin analog results in decreased expression of CCNB1 protein |
decreases expression
|
protein |
22037315
|
D004074 | 891 |
CCNB1
CCNB |
cyclin B1 | Digitoxin analog results in decreased expression of [CCNB1 protein binds to CDK1 protein] |
affects binding
/ decreases expression |
protein |
22037315
|
D004074 | 891 |
CCNB1
CCNB |
cyclin B1 | Digitoxin results in decreased expression of CCNB1 protein |
decreases expression
|
protein |
22037315
|
D004074 | 891 |
CCNB1
CCNB |
cyclin B1 | Digitoxin results in decreased expression of [CCNB1 protein binds to CDK1 protein] |
affects binding
/ decreases expression |
protein |
22037315
|
D004074 | 983 |
CDK1
CDC2 CDC28A P34CDC2 |
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) | Digitoxin analog results in decreased expression of [CCNB1 protein binds to CDK1 protein] |
affects binding
/ decreases expression |
protein |
22037315
|
D004074 | 983 |
CDK1
CDC2 CDC28A P34CDC2 |
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) | Digitoxin analog results in decreased expression of CDK1 protein |
decreases expression
|
protein |
22037315
|
D004074 | 983 |
CDK1
CDC2 CDC28A P34CDC2 |
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) | Digitoxin results in decreased expression of [CCNB1 protein binds to CDK1 protein] |
affects binding
/ decreases expression |
protein |
22037315
|
D004074 | 983 |
CDK1
CDC2 CDC28A P34CDC2 |
cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) | Digitoxin results in decreased expression of CDK1 protein |
decreases expression
|
protein |
22037315
|
D004074 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Digitoxin analog results in decreased expression of CDKN1A protein |
decreases expression
|
protein |
22037315
|
D004074 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | Digitoxin results in decreased expression of CDKN1A protein |
decreases expression
|
protein |
22037315
|
D004074 | 1027 |
CDKN1B
CDKN4 KIP1 MEN1B MEN4 P27KIP1 |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) | Digitoxin analog results in decreased expression of CDKN1B protein |
decreases expression
|
protein |
22037315
|
D004074 | 1027 |
CDKN1B
CDKN4 KIP1 MEN1B MEN4 P27KIP1 |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) | Digitoxin results in decreased expression of CDKN1B protein |
decreases expression
|
protein |
22037315
|
D004074 | 1111 |
CHEK1
CHK1 |
checkpoint kinase 1 (EC:2.7.11.1) | Digitoxin analog results in decreased expression of CHEK1 protein |
decreases expression
|
protein |
22037315
|
D004074 | 1111 |
CHEK1
CHK1 |
checkpoint kinase 1 (EC:2.7.11.1) | Digitoxin results in decreased expression of CHEK1 protein |
decreases expression
|
protein |
22037315
|
D004074 | 11200 |
CHEK2
CDS1 CHK2 HuCds1 LFS2 PP1425 RAD53 hCds1 |
checkpoint kinase 2 (EC:2.7.11.1) | Digitoxin analog results in decreased expression of CHEK2 protein |
decreases expression
|
protein |
22037315
|
D004074 | 11200 |
CHEK2
CDS1 CHK2 HuCds1 LFS2 PP1425 RAD53 hCds1 |
checkpoint kinase 2 (EC:2.7.11.1) | Digitoxin results in decreased expression of CHEK2 protein |
decreases expression
|
protein |
22037315
|
D004074 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | Digitoxin analog results in increased expression of CYCS protein |
increases expression
|
protein |
22037315
|
D004074 | 54205 |
CYCS
CYC HCS THC4 |
cytochrome c, somatic | Digitoxin results in increased expression of CYCS protein |
increases expression
|
protein |
22037315
|
D004074 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]] |
decreases reaction
/ increases activity |
protein |
19446813
|
D004074 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein]] |
decreases reaction
/ increases expression |
protein |
19446813
|
D004074 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Digitoxin inhibits the reaction [IL1B protein results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity |
protein |
19446813
|
D004074 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Digitoxin inhibits the reaction [IL1B protein results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity |
protein |
19446813
|
D004074 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein] |
decreases reaction
/ increases activity |
protein |
19446813
|
D004074 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Digitoxin inhibits the reaction [IL1B protein results in increased expression of CCL2 protein] |
decreases reaction
/ increases expression |
protein |
19446813
|
D004074 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Digitoxin inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
19446813
|
D004074 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Digitoxin results in decreased secretion of IL8 protein |
decreases secretion
|
protein |
15136726
|
D004074 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Digitoxin inhibits the reaction [IL1B protein results in increased activity of MAPK1 protein] |
decreases reaction
/ increases activity |
protein |
19446813
|
D004074 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Digitoxin inhibits the reaction [IL1B protein results in increased activity of MAPK3 protein] |
decreases reaction
/ increases activity |
protein |
19446813
|
D004074 | 4790 |
NFKB1
EBP-1 KBF1 NF-kB1 NF-kappa-B NF-kappaB NFKB-p105 NFKB-p50 NFkappaB p105 p50 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein]] |
decreases reaction
/ increases activity |
protein |
19446813
|
D004074 | 4790 |
NFKB1
EBP-1 KBF1 NF-kB1 NF-kappa-B NF-kappaB NFKB-p105 NFKB-p50 NFkappaB p105 p50 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Digitoxin inhibits the reaction [IL1B protein results in increased activity of NFKB1 protein] |
decreases reaction
/ increases activity |
protein |
19446813
|
D004074 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Digitoxin results in decreased phosphorylation of NFKBIA protein |
decreases phosphorylation
|
protein |
15136726
|
D004074 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin results in increased activity of NOS3 protein] |
decreases reaction
/ increases activity |
protein |
19446813
|
D004074 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | Calcium deficiency inhibits the reaction [Digitoxin results in increased activity of NOS3 protein] |
decreases reaction
/ increases activity |
protein |
19446813
|
D004074 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | Digitoxin results in increased activity of NOS3 protein |
increases activity
|
protein |
19446813
|
D004074 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | Digitoxin analog results in decreased expression of TP53 protein |
decreases expression
|
protein |
22037315
|
D004074 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | Digitoxin results in decreased expression of TP53 protein |
decreases expression
|
protein |
22037315
|
D004074 | 7412 |
VCAM1
CD106 INCAM-100 |
vascular cell adhesion molecule 1 | Digitoxin inhibits the reaction [IL1B protein results in increased expression of VCAM1 protein] |
decreases reaction
/ increases expression |
protein |
19446813
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#104290 | Alternating hemiplegia of childhood 1; ahc1 |
P50993
|
#614820 | Alternating hemiplegia of childhood 2; ahc2 |
P13637
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#128235 | Dystonia 12; dyt12 |
P13637
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#154020 | Hypomagnesemia 2, renal; homg2 |
P54710
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#602481 | Migraine, familial hemiplegic, 2; fhm2 |
P50993
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00831 | Primary dystonia |
P13637
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00775 | Familial or sporadic hemiplegic migraine |
P50993
(related)
|
H00998 | Alternating hemiplegia of childhood |
P50993
(related)
|
H01210 | Hypomagnesemia |
P54710
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D001145 | D004074 | Arrhythmias, Cardiac |
marker/mechanism
|
6022657
|
|
D001281 | D004074 | Atrial Fibrillation |
therapeutic
|
4255107
17460324 |
|
D001282 | D004074 | Atrial Flutter |
marker/mechanism
|
5654317
|
|
D018880 | D004074 | Atrial Premature Complexes |
therapeutic
|
2447325
|
|
D054537 | D004074 | Atrioventricular Block |
marker/mechanism
|
4255107
5654317 5727264 |
|
C535438 | D004074 | Bidirectional tachycardia |
marker/mechanism
|
4781244
12145041 15674736 |
|
D001919 | D004074 | Bradycardia |
marker/mechanism
|
1179459
8212711 |
|
D002037 | D004074 | Bundle-Branch Block |
marker/mechanism
|
15674736
|
|
D002289 | D004074 | Carcinoma, Non-Small-Cell Lung |
therapeutic
|
22037315
|
|
D006332 | D004074 | Cardiomegaly |
therapeutic
|
2436403
|
|
D009202 | D004074 | Cardiomyopathies |
marker/mechanism
|
4909201
5384065 |
|
D002318 | D004074 | Cardiovascular Diseases |
therapeutic
|
19446813
|
|
D003221 | D004074 | Confusion |
marker/mechanism
|
7361148
|
|
D003251 | D004074 | Constriction, Pathologic |
marker/mechanism
|
7059269
|
|
D003693 | D004074 | Delirium |
marker/mechanism
|
7361148
|
|
D003866 | D004074 | Depressive Disorder |
marker/mechanism
|
5643946
|
|
D064420 | D004074 | Drug-Related Side Effects and Adverse Reactions |
marker/mechanism
|
4255107
4418514 4781244 5130149 5447167 7146044 7162976 8212711 15674736 18272488 |
|
D006323 | D004074 | Heart Arrest |
marker/mechanism
|
7119638
|
|
D006331 | D004074 | Heart Diseases |
therapeutic
|
11532201
|
|
D006333 | D004074 | Heart Failure |
therapeutic
|
18272488
|
|
D006530 | D004074 | Hepatorenal Syndrome |
therapeutic
|
11051385
|
|
D006973 | D004074 | Hypertension |
therapeutic
|
11016824
|
|
D007022 | D004074 | Hypotension |
marker/mechanism
|
11016824
|
|
D020925 | D004074 | Hypoxia-Ischemia, Brain |
marker/mechanism
|
14574425
|
|
D053609 | D004074 | Lethargy |
marker/mechanism
|
7361148
|
|
C537347 | D004074 | Mesenteric vascular disease |
marker/mechanism
|
7059269
|
|
D009069 | D004074 | Movement Disorders |
marker/mechanism
|
7146044
7361148 |
|
D020258 | D004074 | Neurotoxicity Syndromes |
marker/mechanism
|
14574425
|
|
D010554 | D004074 | Personality Disorders |
marker/mechanism
|
7361148
|
|
D011660 | D004074 | Pulmonary Heart Disease |
therapeutic
|
4018179
|
|
D012021 | D004074 | Reflex, Abnormal |
marker/mechanism
|
7146044
|
|
D012640 | D004074 | Seizures |
marker/mechanism
|
5569832
5643946 7146044 |
|
D012804 | D004074 | Sick Sinus Syndrome |
marker/mechanism
|
17460324
|
|
D012848 | D004074 | Sinoatrial Block |
marker/mechanism
|
8212711
|
|
D013617 | D004074 | Tachycardia, Supraventricular |
marker/mechanism
therapeutic |
2447325
4255107 5727264 |
|
D017180 | D004074 | Tachycardia, Ventricular |
marker/mechanism
|
914999
4255107 |
|
D013921 | D004074 | Thrombocytopenia |
marker/mechanism
|
8212711
|
|
D014202 | D004074 | Tremor |
marker/mechanism
|
7146044
|
|
D014549 | D004074 | Urinary Incontinence |
marker/mechanism
|
7361148
|
|
D020301 | D004074 | Vasospasm, Intracranial |
marker/mechanism
|
14574425
|
|
D018487 | D004074 | Ventricular Dysfunction, Left |
therapeutic
|
4018179
|
|
D014693 | D004074 | Ventricular Fibrillation |
marker/mechanism
|
11808
7162976 |
|
D018879 | D004074 | Ventricular Premature Complexes |
marker/mechanism
|
4255107
|